Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,878 | 5 | 0 | 1 | 18 |
| Marketable Securities | 83 | N/A | N/A | N/A | N/A |
| Receivables | 4,872 | N/A | N/A | N/A | N/A |
| Other current assets | 344 | 0 | 4 | 4 | 4 |
| TOTAL | $7,177 | $5 | $5 | $6 | $23 |
| Non-Current Assets | |||||
| PPE Net | 73 | N/A | N/A | N/A | N/A |
| Intangibles | 6,585 | 0 | 0 | 0 | 0 |
| TOTAL | $6,658 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $13,835 | $5 | $5 | $6 | $23 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,236 | N/A | 2 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,247 | 9 | 23 | 18 | 18 |
| TOTAL | $8,576 | $9 | $25 | $26 | $18 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,000 | 0 | 0 | 0 | 0 |
| TOTAL | $5,000 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $13,576 | $9 | $25 | $26 | $18 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 15,410 | 15,410 | 12,142 | N/A |
| Common Shares | 119 | 154 | 121 | 121 | 121 |
| Retained earnings | -1,053 | -47,426 | -47,393 | -47,392 | -47,368 |
| TOTAL | $259 | $-4 | $-20 | $-20 | $5 |
| Total Liabilities And Equity | $13,835 | $5 | $5 | $6 | $23 |